Skip to content

Effectiveness of Metronidazole in Pain Control Posthemorrhoidectomy

Effectiveness of Metronidazole Versus Homologated Placebo in Pain Control Posthemorrhoidectomy

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02328144
Enrollment
44
Registered
2014-12-31
Start date
2013-07-31
Completion date
2014-10-31
Last updated
2014-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids

Keywords

Hemorrhoidectomy, Postoperative pain, Metronidazole

Brief summary

Hemorrhoidal disease occurs in 50% of people over 40 years old and is the most common cause of anorectal surgery. One of the complications of hemorrhoidectomy is pain, which is a difficult symptom to appreciate and assess, by its frequent and large variations in sensitivity in each patient. Many studies have been done to reduce patient postoperative pain, but there is no ideal method. The application of both oral and topical metronidazole has shown to decrease pain following hemorrhoidectomy, but its use is not standardized. The investigators evaluated the effect of oral administration of metronidazole versus homologated placebo in pain control after hemorrhoidectomy

Detailed description

Objective: Evaluate the effect of oral administration of metronidazole versus homologated placebo in pain control after hemorrhoidectomy. Material and methods: Controlled clinical trial, composed of 44 patients in a randomized manner, realized at the Coloproctology, Western Medical Center, Mexican Institute of Social Security. Referred beneficiaries adults were included, of either sex, who merited elective hemorrhoidectomy for hemorrhoidal disease grades III-IV using Ferguson's technique. They were assigned to receive metronidazole (study group) or homologated (control group) and the randomization was conducted by sealed envelopes and subsequently. We collected demographic and clinical variables. Postoperative pain was assessed by visual analog scale at 6 and 12hrs, 1, 4, 7 and 14 days; additional analgesic use; complications; return to normal activity and patient satisfaction; also were measured, in a blood sample after surgery and 12 hrs later, interleukin 6 and 10. The statistical analysis was performed according to the nature of variables, for continuous data using measures of central tendency and dispersion and for the qualitative data with frequencies and percentages

Interventions

DRUGMetronidazole

Patients were assigned to two groups, one of them received oral metronidazole (study group) and the other, homologated placebo (control group) after hemorrhoidectomy. Then, postoperative pain was assessed by visual analog scale at 6 and 12hrs, 1, 4, 7 and 14 days

DRUGPlacebo

Patients were assigned to two groups, one of them received oral metronidazole (study group) and the other, homologated placebo (control group) after hemorrhoidectomy. Then, postoperative pain was assessed by visual analog scale at 6 and 12hrs, 1, 4, 7 and 14 days.

Sponsors

Instituto Mexicano del Seguro Social
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hemorrhoidal disease grade III and IV * Informed consent

Exclusion criteria

* Pregnancy * Lactation * Other anorectal disease * Previous anorectal * hypersensibility to metronidazole

Design outcomes

Primary

MeasureTime frameDescription
Pain evolution, hours and days after surgery6 and 12 hours, 1, 4, 7 and 14 daysPain was assessed with the visual analogue scale questionnaire

Secondary

MeasureTime frameDescription
Interleukinafter surgery and 12 hoursIn a blood sample, right after surgery and 12 hours later, interleukin 6 and 10 were measured by ELISA, observing if they presented alterations with the intervention, between 2 groups and between the hours the investigators took the blood sample
Analgesics6 and 12 hours, 1, 4, 7 and 14 daysUsing a questionnaire if they used analgesics, which one, dose of it and how many days
Surgery complications6 and 12 hours, 1, 4, 7 and 14 daysAsking directly to participants if they presented bleeding, urinary retention or another complication. Investigators measured how many participants presented complications
Return to normal activities1, 4, 7 and 14 daysAsking to participans when they return to normal activities (to walk normally, to cook, to bath, to wear, to work) How many days were needed to recover their normal activities
Satisfaction14 dayAsking how they felt in last 14 days and what was their perception of the surgery

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026